A large observational study using US healthcare claims and electronic health record data suggests that Moderna’s updated 2024 ...
(NewsNation) — Moderna reports it has received full approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Spikevax, in children six months through 11 years of age, who are at ...
Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback